KN95

KN95 is not a single manufacturer-owned consumer brand or corporate group. It is a designation associated with respirators manufactured to the Chinese standard GB 2626, historically written as GB 2626-2006 and subsequently revised as GB 2626-2019. The designation is commonly used for disposable, tight-fitting filtering facepiece respirators intended to reduce exposure to airborne particles. The “KN” classification refers to a category of non-oil-resistant particulate respirators under the Chinese standard, while “95” indicates a minimum filtration efficiency of 95% under the standard’s test conditions. The designation is therefore analogous in broad purpose to other national respirator classifications, including N95 in the United States, FFP2 in Europe, and KF94 in South Korea. These classifications are not automatically interchangeable: each system uses its own testing, labeling, fit, quality-control, and approval requirements. KN95 products became especially visible outside China during the COVID-19 pandemic. Global shortages of medical masks and respirators led governments, hospitals, employers, and consumers to source products from international manufacturers. In the United States, federal agencies created temporary or emergency pathways for evaluating certain respirators made to foreign standards, including KN95 products, when supplies of U.S.-approved N95 respirators were constrained. The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention emphasized that a KN95 designation alone did not establish approval by the U.S. National Institute for Occupational Safety and Health (NIOSH), nor did it guarantee that a particular product had been properly manufactured or tested. A major distinction is that a KN95 respirator may be an occupational or personal protective product without being a surgical mask or medical device approved for every clinical use. Medical claims, fluid resistance, sterilization, fit, ear-loop construction, headband design, and certification status can vary by product and market. Ear-loop respirators may also achieve different real-world fit from headband-equipped respirators, because protection depends not only on filter performance but also on seal quality and proper wearing. KN95 is consequently best understood as a technical product designation rather than a unified brand with one owner, headquarters, founder, executive team, or official website. Numerous unrelated manufacturers and sellers have used the term, and counterfeit, mislabeled, or nonconforming products have been reported by regulators. Buyers and institutions generally need to verify the manufacturer, model, applicable standard, markings, documentation, and regulatory status in the relevant market rather than treating the KN95 name as a guarantee of performance.

KN95 developed as a product designation within China’s respiratory-protection standards rather than as a conventional brand. The designation is linked to the GB 2626 standard for respiratory protective equipment, which specifies requirements and test methods for particulate-filtering respirators. In this framework, “KN” identifies a non-oil-resistant particulate-filtering category and “95” denotes a stated minimum filtration efficiency of 95% under the standard’s laboratory conditions. The designation became widely recognizable in China and in international supply chains as manufacturers produced disposable filtering facepiece respirators for industrial, occupational, and public-health uses. Because the designation is applied by multiple manufacturers, KN95 products can differ in construction, fit system, labeling, quality controls, regulatory documentation, and intended use. The name itself does not identify one company or guarantee that every product bearing it conforms to the relevant standard. International awareness rose sharply during the COVID-19 pandemic. Severe demand for respiratory protection and shortages of N95 respirators prompted governments and health systems to examine products certified or represented as meeting foreign standards. In the United States, the FDA issued emergency-use policies for certain non-NIOSH-approved respirators, including some products represented as KN95. The CDC and NIOSH also published technical guidance and testing information for imported respirators. These measures were emergency responses to shortages and did not convert KN95 into a U.S. NIOSH approval category. Testing during the pandemic identified substantial variation among imported and domestically sold respirators. Some products marketed under foreign classifications performed adequately in laboratory evaluations, while others failed to meet their claimed filtration performance or had labeling and documentation problems. Regulators therefore stressed model-specific verification, traceability, fit, and correct use. The distinction between a respirator and a loose-fitting face covering also remained important: filtration efficiency measured on filter material does not by itself establish the protection achieved on a wearer’s face. The Chinese standard associated with KN95 was revised from GB 2626-2006 to GB 2626-2019. The revised standard retained the broader KN and KP particulate-filtering framework while updating technical requirements and test provisions. Products may continue to show different standard-year markings depending on their manufacturing, certification, and market context. Today, KN95 remains a widely recognized term in the global respiratory-protection market, but it should be treated as a classification or product designation rather than a single brand. There is no central KN95 corporation, executive team, headquarters, or universal retail channel. Assessment depends on the specific manufacturer and model, the standard claimed on the product, the certification or authorization applicable in the target market, and whether the product has been tested and fitted appropriately.

• 2020

  KN95 becomes globally prominent during the COVID-19 respirator shortage

  [1]CDC/NIOSH information on non-NIOSH-approved respiratorscdc.gov

  International shortages of N95 and comparable respirators lead buyers and regulators to source and evaluate products made to foreign standards, including KN95.

• 2020

  U.S. emergency-use policies cover certain foreign-standard respirators

  [3]U.S. FDA emergency use authorizations for medical devicesfda.gov

  The FDA creates temporary regulatory pathways for selected respirators made to standards outside the United States, subject to specified conditions and evidence.

• 2019

  China revises the respiratory-protection standard

  [4]China National Public Service Platform for Standards Informationopenstd.samr.gov.cn

  China publishes GB 2626-2019, a revision of the standard for respiratory protective equipment with non-powered air-purifying particulate filters.

• 2006

  GB 2626-2006 becomes a major reference for Chinese particulate respirators

  [5]GB 2626-2006 becomes a major reference for Chinese particulate respiratorsiso.org

  The Chinese respiratory-protection standard GB 2626-2006 provided the technical framework commonly associated with KN-class and KP-class particulate-filtering respirators.

A cross-border particulate-respirator designation associated with the Chinese GB 2626 standard, positioned as a high-filtration alternative to ordinary loose-fitting face masks. KN95 is not a unified manufacturer brand, and the designation does not by itself establish approval in another country.

• Respiratory protective equipment

  KN95 disposable filtering facepiece respirator

  A tight-fitting, disposable particulate-filtering respirator marketed under the KN95 designation. Common constructions include folded and cup-shaped designs, with elastic ear loops or headbands. Performance depends on the specific model’s filter media, manufacturing quality, seal, fit, and compliance documentation. The designation is not a guarantee of NIOSH approval or of suitability for every medical or occupational application.

• Respiratory protective equipment

  KN95 children’s respirator

  A smaller respirator marketed for children under a KN95 designation. Child-sized products require particular attention to dimensions, fit, breathing resistance, labeling, and intended use. A child-oriented label does not by itself establish regulatory approval or an effective seal for a particular wearer.

• 2020

  Counterfeit and nonconforming imported respirators

  During the COVID-19 supply shortage, regulators and testing organizations reported counterfeit, mislabeled, or underperforming respirators marketed as meeting foreign standards, including KN95. The issue concerned particular products and suppliers rather than a single KN95 corporate entity.

  Source

Read more

• 2020

  Emergency acceptance of selected foreign-standard respiratorsStrategy

  Background

  The United States faced an acute shortage of N95 respirators and other filtering facepiece respirators during the COVID-19 pandemic.

  Action taken

  The FDA and related agencies established temporary pathways for evaluating certain respirators made to foreign standards, including some products represented as KN95, while retaining conditions concerning testing, labeling, and use.

  Aftermath

  The measures expanded short-term supply options but also increased scrutiny of authenticity, filtration performance, fit, and the difference between emergency authorization and ordinary NIOSH approval.

  Source

1. 1CDC/NIOSH information on non-NIOSH-approved respiratorscdc.gov
2. 2U.S. FDA information on masks, respirators, and face coveringsfda.gov
3. 3U.S. FDA emergency use authorizations for medical devicesfda.gov
4. 4China National Public Service Platform for Standards Informationopenstd.samr.gov.cn
5. 5GB 2626-2006 becomes a major reference for Chinese particulate respiratorsiso.org